Association between Ophthalmological Changes and Cardiovascular Diseases in Patients with Chronic Kidney Disease

Hirohiko Nokiba1, Takashi Takei, Chikako Suto

  • 1Department of Medicine, Kidney Center, Tokyo Women's Medical University.

Insights

Retinal arterial sclerosis, assessed by the Scheie S grade, is linked to arterial stiffness and cardiovascular disease (CVD) history in hemodialysis patients. This retinopathy classification may help predict CVD risk in chronic kidney disease patients.

Area of Science:

  • Ophthalmology
  • Nephrology
  • Cardiology

Background:

  • Patients with chronic kidney disease (CKD) undergoing hemodialysis (HD) have a high prevalence of cardiovascular diseases (CVD).
  • Arterial sclerosis is a key factor in CVD development.
  • The association between retinal arterial sclerosis and CVD in CKD patients on HD remains understudied.

Purpose of the Study:

  • To assess retinal arterial sclerosis in patients with CKD on HD.
  • To investigate the relationship between retinal arterial changes and arterial stiffness.
  • To explore the link between retinal arterial changes and a past history of CVD.

Main Methods:

  • Data from 44 CKD patients on HD were analyzed.
  • Ophthalmological findings, including Scheie classification of retinopathy, were evaluated.
  • Arterial stiffness (pulse wave velocity) and past CVD history were assessed; medications and biochemical parameters were recorded.

Main Results:

  • A significant correlation was observed between arteriosclerotic retinopathy (Scheie S grade) and arterial stiffness (p=0.001).
  • The presence of arteriosclerotic retinopathy was also significantly associated with a past history of CVD (p=0.045).
  • No other ophthalmological findings correlated with arterial stiffness or CVD history.

Conclusions:

  • Retinopathy classification, specifically the Scheie S grade, may serve as a useful indicator for predicting arterial stiffness.
  • Ophthalmoscopic examination of retinopathy can help identify patients at higher risk for arterial stiffness and associated CVD.
  • This study highlights a potential non-invasive method for risk stratification in CKD patients on HD.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
996
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
630
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
637
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.9K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
733